Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best CJC-1295 Dosage Sustained GH Elevation 2026: Protocol Comparison

Conservative Tri-Weekly 1.5–2.1 mg/week 500–700 mcg 3× weekly (M/W/F) 60–80% above baseline 6–8 days per dose Minimal through week 12 Gold standard for sustained elevation without receptor downregulation. Preserves endogenous pulsatility Moderate Bi-Weekly 2–2

This comparison does not assign a generated winner or score.

  • Conservative Tri-Weekly
  • 1.5–2.1 mg/week
  • 500–700 mcg 3× weekly (M/W/F)
  • 60–80% above baseline
  • 6–8 days per dose
  • Minimal through week 12
  • Gold standard for sustained elevation without receptor downregulation. Preserves endogenous pulsatility
  • Moderate Bi-Weekly
  • 2–2.4 mg/week
  • 1–1.2 mg 2× weekly (Mon/Thu)
  • 50–70% above baseline
  • 5–7 days per dose
  • Detectable decline week 8–10
  • Effective compromise between convenience and sustainability. Suitable for experienced users
  • Single Weekly High-Dose
  • 2–3 mg/week
  • 2–3 mg 1× weekly
  • 40–60% above baseline (declining)
  • 3–5 days per dose
  • Significant by week 6
  • Produces acute spike followed by rebound suppression. Not recommended for sustained elevation goals
  • CJC + Ipamorelin Stack
  • 1.8 mg CJC + 0.6 mg Ipa/week
  • 600 mcg CJC + 200 mcg Ipa 3× weekly
  • 100–150% above baseline
  • 7–9 days per dose
  • Minimal through week 16+
  • Synergistic protocol leveraging dual pathways. Best option for maximizing sustained GH without tolerance
More references

Related material